Effect of the Physiological Angular Position of the Resting Knee on Pressure at the Heel/Surface Interface
FlessCare
2 other identifiers
observational
65
1 country
1
Brief Summary
The main objective of this study is to evaluate the relationship between the angle of knee flexion in a supine position with joint relaxation (DDPD) and the maximum interface pressure at the heel area (PtAl).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2013
CompletedFirst Posted
Study publicly available on registry
November 6, 2013
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedMarch 26, 2015
March 1, 2015
2 months
October 30, 2013
March 25, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Measurement 1: Measurement of the knee joint angle (degrees °) in a physiological relaxed position (supine)(via photos of first skin marks).
Day 0
Measurement 2: Measurement of the knee joint angle (degrees °) in a physiological relaxed position (supine)(via photos of first skin marks)
Day 0
Maximum pressure on the heel area (Ptal)
Day 0
Secondary Outcomes (5)
Mean pressure over the entire heel area (P mean)
Day 0
Measurement of the contact surface of the heel zone (Stal) having a pressure greater than 60 mmHg
Day 0
Concordance for measurements 1 & 2 for knee flexion angle in a relaxed supine position (via photos)
Day 0
Concordance for skin marks for knee flexion angles between 2 operators for 30 knees.
Day 0
Intra-operator concordance for skin marks used for measuring knee flexion angle for 30 knees
Day 1
Other Outcomes (5)
Age
Day 0
Sex
Day 0
Weight (kg)
Day 0
- +2 more other outcomes
Study Arms (1)
The study population
Only one group is included. See inclusion/exclusion criteria. Intervention: Knee flexion measurement 1 Intervention: Knee flexion measurement 2 Intervention: Heel - interface pressure measurements
Interventions
The angle of knee flexion during resting, supine position is measured by a first person.
The angle of knee flexion during resting, supine position is measured by a second person.
The pressure analysis system used is the X Sensor X3 model (Xsensor Technology Corporation, Calgary, Canada). The sensor mat is made up of transducer cells, each measuring 1.6 cm\^2. The digital signal is transmitted to a PC via a USB port at a sampling frequency of 10Hz. Before each measurement, the sensor mat is calibrated from 10 to 220 mm Hg, according to the manufacturer's recommendations. The sheet of pressure sensors is disposed on the dedicated bed. The patient is then asked to take his/her usual position in the supine position and a latency of 5 minutes is observed. The recording time pressure is then performed for 90 seconds in the optical observing time to adapt to changes in media.
Eligibility Criteria
The study population consists of consecutive patients admitted in the functional rehabilitation unit of the Nîmes University Hospital.
You may qualify if:
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- The patient is in a stable medical state (no complications within the past 10 days)
You may not qualify if:
- The patient is participating in another study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient has a bed-sore or bandages on his/her heels
- The patient has had a lower-limb amputation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
Study Officials
- PRINCIPAL INVESTIGATOR
Emilie Viollet, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2013
First Posted
November 6, 2013
Study Start
March 1, 2014
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
March 26, 2015
Record last verified: 2015-03